Balch, A. and Mackin, A. 2007. Canine immune- mediated hemolytic anemia: pathophiosology, clinical sign, and diagnosis. Compend. Contin. Educ. Vet., 29(4): 217-225.

Barker, R.N., Gruffydd-Jones, T.J., Stokes, C.R. and Bourne, F.J. 1992. Autoimmune haemolysis in the dog: relationship between anaemia and the levels of red blood cell bound immunoglobulins and complement complement measured by an enzyme-linked antiglobulin test. Vet. Immunol. Immunopathol., 34: 1–20.

Burgess, K., Moore, A. and Rand, W. 2000. Treatment of immunemediated hemolytic anemia in dogs with Cyclophosphamide. J. Vet. Intern. Med., 14(4): 456-462.

Dowling, P.M. 1995. Immunosuppressive drug therapy. Can. Vet. J., 36(12): 781-783.

Giger, U. 2005.Regenerative anemias caused by blood loss or hemolysis. In: Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine, 6th Edn,. St Louis, Saunders, pp. 1886–1907.

Jackson, M.L. and Kruth, S.A. 1985. Immune-mediated hemolytic anemia and thrombocytopenia in dogs: a retrospective study of 55 cases diagnosed from 1969 through 1983 at the western college of veterinary medicine. Can. Vet.J. Res., 26(8): 245-250.

Klag , A., Giger , U. and Shofer, F. 1993. Idiopathic immunemediated hemolytic anemia in dogs: 42 cases (1986– 1990). J. Am. Vet. Med. Assoc., 202 (5): 783–788.

Kledmanee, K., Suwanpakdee, S., Krajangwong, S., Chatsiriwech, J., Sukasai, P., Suwannachat, P.,Sariya, L., Buddhirongawatr, R., Charoonrut, P. and Chaichoun, K. 2009. Development of multiplex polymerase chain reaction for detection of Ehrlichia canis, Babesia spp. and Hepatazoan canis in canine blood. Southeast Asian T. Med. Public Health, 40(1): 35–39.

Kucinskiene, G., Schuberth, H.J., Leibold, W.J. and Pieskus, J. 2005. Flow cytometric evaluation of bound IgG on erythrocytes of anaemic dogs. Vet. J., 169: 303–307.

Mason, N., Duval, D., Shofer, F.S. and Giger, U. 2003. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J. Vet. Intern. Med., 17(2): 206–212.

McAlees, T.J. 2010. Immune-mediated hemolytic anaemia in 110 dogs in Victoria, Australia. Aust. Vet. J., 88: 25-28.

McManus, P. and Craig, L.2001. Correlation between leukocytosis and necropsy finding in dogs with immune mediated hemolytic anemia: 34 cases (1994– 1999). JAVMA., 218(8): 1308–1313.

Piek, C.J. 2011. Canine idiopathic immune-mediated hemolytic anemia: a review with recommendations for future research. Vet. Q., 31: 129–141.

Rinkardt, N.E. and Kruth, S.A. 1996. Azathioprine-induced bone marrow toxicity in four dogs. Can. Vet. J., 37: 612-613.

Scott-Moncrieff, J.C., Treadwell, N.G. and McCullough, S.M. 2001. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J. Am. Anim. Hosp. Assoc., 37: 220-227.

Suzuki, K., Wakabayashi, H., Takahash, M., Fukushima, K., Yabuki, K. and Endo, Y. 2007. A possible treatment strategy and clinical factors to estimate the treatment response inBabesia gibsoni infection. J. Vet. Med. Sci., 69(5): 563–568.

Wang, A., Smith, J.R. and Creevy, K.E. 2013. Treatment of canine idiopathic immune mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011). J. Small. Anim. Pract., 54(8): 399–404.

Weinkle, T.K., Center, S.A., Randolph, J.F., Warner, K.L., Barr, S.C. and Erb, H.N. 2005. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J. Am. Vet. Med. Assoc., 226: 1869-1880.

Whitley, N.T. and Day, M.J. 2011. Immunomodulatory drugs and their application to the management of canine immunemediated disease. J. Small. Anim. Pract., 52(2): 70–85.